Showing 1 - 9 results of 9 for search 'Wenyan Chen', query time: 0.18s Refine Results
  1. 1
    A Lotka-Volterra Competition Model with Cross-Diffusion

    A Lotka-Volterra Competition Model with Cross-Diffusion by Wenyan Chen, Ya Chen

    Published 2013-01-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Metabolic syndrome is associated with prognosis in patients with acute ischemic stroke after intravenous thrombolysis: a prospective cohort study

    Metabolic syndrome is associated with prognosis in patients with acute ischemic stroke after intravenous thrombolysis: a prospective cohort study by Wenyan Chen, Dandan Liu, Zhiqiang Li, Xiaofang Zhang

    Published 2025-07-01
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    Unveiling the Hidden Mechanism: How LuxS/AI-2 quorum sensing system drives antimicrobial resistance in Salmonella pullorum through activation of the efflux pump AcrAB-TolC

    Unveiling the Hidden Mechanism: How LuxS/AI-2 quorum sensing system drives antimicrobial resistance in Salmonella pullorum through activation of the efflux pump AcrAB-TolC by Ziheng Xu, Can Wang, Min Wang, Jingzhen Liang, Changcheng Li, Wenyan Chen, Ping Wei

    Published 2025-04-01
    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    Dynamic changes in peripheral inflammation as a risk factor for perioperative sleep disturbances in elderly patients undergoing laparoscopic hepatobiliary surgery

    Dynamic changes in peripheral inflammation as a risk factor for perioperative sleep disturbances in elderly patients undergoing laparoscopic hepatobiliary surgery by Lai Wei, Lai Wei, Lai Wei, Xiaoyu Zhu, Yiming Zhao, Yi Zou, Tao Hu, Qian Huang, Jieqiong Li, Bingbing Pan, Bingbing Pan, Gaoyin Kong, Gaoyin Kong, Gaoyin Kong, Siyou Tan, Siyou Tan, Wenyan Chen, Wenyan Chen

    Published 2025-04-01
    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    Enhancer RNA Transcriptome‐Wide Association Study Reveals a Distinctive Class of Pan‐Cancer Susceptibility eRNAs

    Enhancer RNA Transcriptome‐Wide Association Study Reveals a Distinctive Class of Pan‐Cancer Susceptibility eRNAs by Wenyan Chen, Zeyang Wang, Yinuo Wang, Jianxiang Lin, Shuxin Chen, Hui Chen, Xuelian Ma, Xudong Zou, Xing Li, Yangmei Qin, Kewei Xiong, Xixian Ma, Qi Liao, Yunbo Qiao, Lei Li

    Published 2025-04-01
    Get full text
    Article
    Save to List
    Saved in:
  6. 6
    Lnk deficiency attenuates the immunosuppressive capacity of MDSCs via ferroptosis to suppress tumor development

    Lnk deficiency attenuates the immunosuppressive capacity of MDSCs via ferroptosis to suppress tumor development by Jingwen Zhou, Hui Yin, JiaHua Pan, Rui Yin, Xin Wei, Min Shen, Liangliang Cai, Ziqi Liu, Jie Zhao, Wenyan Chen, Ruoxun Wang, Xinrui Lan, Wenshu Han, Dongkun Li, Xiaoyu Zhu, Weijuan Gong, Li Qian

    Published 2025-08-01
    Get full text
    Article
    Save to List
    Saved in:
  7. 7
    Dalpiciclib combined with pyrotinib and endocrine therapy in women with ER-positive, HER2-positive advanced breast cancer: A prospective, multicenter, single-arm, phase 2 trial.

    Dalpiciclib combined with pyrotinib and endocrine therapy in women with ER-positive, HER2-positive advanced breast cancer: A prospective, multicenter, single-arm, phase 2 trial. by Jian Zhang, Yanchun Meng, Biyun Wang, Xinhong Wu, Hongmei Zheng, Jing Hu, Wei Liu, Wenyan Chen, Leiping Wang, Jun Cao, Zhonghua Tao, Ting Li, Sujie Ni, Zhengyan Yu, Lichun Sun, Yun Wang, Qiang Peng, Song Wang, Xin Hu, Jianfei Wang, Yijia Wu, Xichun Hu

    Published 2025-07-01
    Get full text
    Article
    Save to List
    Saved in:
  8. 8
    Dalpiciclib combined with pyrotinib and endocrine therapy in women with ER-positive, HER2-positive advanced breast cancer: A prospective, multicenter, single-arm, phase 2 trial

    Dalpiciclib combined with pyrotinib and endocrine therapy in women with ER-positive, HER2-positive advanced breast cancer: A prospective, multicenter, single-arm, phase 2 trial by Jian Zhang, Yanchun Meng, Biyun Wang, Xinhong Wu, Hongmei Zheng, Jing Hu, Wei Liu, Wenyan Chen, Leiping Wang, Jun Cao, Zhonghua Tao, Ting Li, Sujie Ni, Zhengyan Yu, Lichun Sun, Yun Wang, Qiang Peng, Song Wang, Xin Hu, Jianfei Wang, Yijia Wu, Xichun Hu

    Published 2025-07-01
    Get full text
    Article
    Save to List
    Saved in:
  9. 9
    Capivasertib plus fulvestrant in patients with HR-positive/HER2-negative advanced breast cancer: phase 3 CAPItello-291 study extended Chinese cohort

    Capivasertib plus fulvestrant in patients with HR-positive/HER2-negative advanced breast cancer: phase 3 CAPItello-291 study extended Chinese cohort by Xichun Hu, Qingyuan Zhang, Tao Sun, Huihua Xiong, Wei Li, Yuee Teng, Yen-Shen Lu, Ling-Ming Tseng, Min Yan, Hongsheng Li, Danmei Pang, Shin-Cheh -Chen, Wenyan Chen, Ou Jiang, Jingfen Wang, Xinhong Wu, Xian Wang, Aimin Zang, Xiaojia Wang, Julie M. Collins, Ethan Fan, Lin Jiang, Xiaoling Zeng, Nicholas C. Turner

    Published 2025-05-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: